Functional expression and characterization of the C. elegans G-protein-coupled FLP-2 Receptor (T19F4.1) in mammalian cells and yeast

被引:12
作者
Larsen, Martha J. [1 ]
Lancheros, Elizabeth Ruiz [2 ]
Williams, Tracey [1 ]
Lowery, David E. [1 ]
Geary, Timothy G. [1 ]
Kubiak, Teresa M. [1 ]
机构
[1] Pfizer Anim Hlth Discovery Res, Vet Med Discovery Res, Kalamazoo, MI 49001 USA
[2] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada
来源
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE | 2013年 / 3卷
关键词
FLP; Caenorhabditis elegans; flp2; Neuropeptide; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; NERVOUS-SYSTEM; GENE FAMILIES; NEUROPEPTIDE; PEPTIDES; IDENTIFICATION; CLONING; NEUROTRANSMITTERS;
D O I
10.1016/j.ijpddr.2012.10.002
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Profound neuropeptide diversity characterizes the nematode nervous system, but it has proven challenging to match neuropeptide G protein-coupled receptors (GPCR) with their cognate ligands in heterologous systems. We have expressed the Caenorhabditis elegans GPCR encoded in the locus T19F4.1, previously matched with FMRFamide-like peptides encoded on the flp-2 precursor gene, in mammalian cells and in the yeast Saccharomyces cerevisiae. Pharmacological characterization revealed that the receptor is potently activated by flp-2 peptides in CHO cells (similar to 10 nM EC50) and in yeast (similar to 100 nM EC50), signaling through a G(q)alpha pathway in each system. The yeast GPCR expression system provides a robust assay for screening for agonists of the flp-2 receptor and is the target of an ongoing high-throughput screening exercise. (C) 2012 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 58 条
  • [1] [Anonymous], 1998, Science, V282, P2018
  • [2] Neurobiology of the Caenorhabditis elegans genome
    Bargmann, CI
    [J]. SCIENCE, 1998, 282 (5396) : 2028 - 2033
  • [3] Bastiani C., 2006, WORMBOOK, DOI DOI 10.1895/W0RMB00K.1.75.1
  • [4] RNAi-based discovery and validation of new drug targets in filarial nematodes
    Behm, CA
    Bendig, MM
    McCarter, JP
    Sluder, AE
    [J]. TRENDS IN PARASITOLOGY, 2005, 21 (03) : 97 - 100
  • [5] The molecular evolution of the allatostatin precursor in cockroaches
    Bellés, X
    Graham, LA
    Bendena, WG
    Ding, Q
    Edwards, JP
    Weaver, RJ
    Tobe, SS
    [J]. PEPTIDES, 1999, 20 (01) : 11 - 22
  • [6] BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756
  • [7] Broach JR, 1996, NATURE, V384, P14
  • [8] Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO
  • [9] 2-K
  • [10] Pharmacology of GPR55 in Yeast and Identification of GSK494581A as a Mixed-Activity Glycine Transporter Subtype 1 Inhibitor and GPR55 Agonist
    Brown, Andrew J.
    Daniels, Dion A.
    Kassim, Mumta
    Brown, Sue
    Haslam, Carl P.
    Terrell, Victoria R.
    Brown, Jason
    Nichols, Paula L.
    Staton, Penny C.
    Wise, Alan
    Dowell, Simon J.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 337 (01) : 236 - 246